1,837 results on '"Berkhout, Ben"'
Search Results
2. In-house ELISA protocols for capsid p24 detection of diverse HIV isolates
3. HIV co-opts a cellular antiviral mechanism, activation of stress kinase PKR by its RNA, to enable splicing of rev/tat mRNA
4. Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
5. ‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence
6. AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery
7. CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures
8. Reverse transcription of HIV-1 2-LTR circle transcripts does frequently cause 3'-polypurine tract mutations implicated in dolutegravir resistance
9. FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation
10. HIV persistence: silence or resistance?
11. CRISPR-Cas-Based Gene Therapy to Target Viral Infections
12. CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA
13. PA-305 FC gamma receptor gene polymorphisms and reservoir size in HIV patients in Ghana
14. Towards a molecular profile of antiretroviral therapy-free HIV remission
15. Viruses in the reproductive tract: On their way to the germ line?
16. Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships
17. Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination
18. Human Immunodeficiency Virus Resistance to Dolutegravir : Are We Looking in the Wrong Place?
19. Elimination of infectious HIV DNA by CRISPR–Cas9
20. Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines
21. Influence of a 3′ Terminal Ribozyme on AgoshRNA Biogenesis and Activity
22. Assessing proviral competence: current approaches to evaluate HIV-1 persistence
23. HIV-1 3′-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR Circles
24. DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users
25. Design and Evaluation of AgoshRNAs with 3′-Terminal HDV Ribozymes to Enhance the Silencing Activity
26. Design and Evaluation of Guide RNA Transcripts with a 3′-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation
27. The evolution of subtype B HIV-1 tat in the Netherlands during 1985–2012
28. CRISPR-Cas based antiviral strategies against HIV-1
29. Gene Therapy Strategies to Block HIV-1 Replication by RNA Interference
30. Human Coronavirus NL63 Employs the Severe Acute Respiratory Syndrome Coronavirus Receptor for Cellular Entry
31. Data from Construction of a Minimal HIV-1 Variant that Selectively Replicates in Leukemic Derived T-Cell Lines: Towards a New Virotherapy Approach
32. Supplementary Figure 1 from Construction of a Minimal HIV-1 Variant that Selectively Replicates in Leukemic Derived T-Cell Lines: Towards a New Virotherapy Approach
33. Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
34. From clinical sample to complete genome: Comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing
35. In vitro Evolution of a Highly Replicating, Doxycycline-Dependent HIV for Applications in Vaccine Studies
36. A trip down memory lane with Retrovirology
37. HIV Infection and Adipose Tissue Resident Stem Cells: Their Involvement in Pathology and Treatment
38. A CRISPR-Cas Cure for HIV/AIDS
39. Reverse Transcriptase Fidelity and HIV-1 Variation
40. 137 FcγRIIa-specific DARPins as a novel tool toward specific gene delivery into HIV reservoir cells
41. Conditionally replicating HIV and SIV variants
42. A Conditionally Replicating Human Immunodeficiency Virus in BRG-HIS Mice
43. Workup of Human Blood Samples for Deep Sequencing of HIV-1 Genomes
44. On the generation of the MSD-Ѱ class of defective HIV proviruses
45. On the biased nucleotide composition of the human coronavirus RNA genome
46. RNAi as Antiviral Therapy: The HIV-1 Case
47. On the nucleotide composition and structure of retroviral RNA genomes
48. HIV-phyloTSI: Subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data
49. Silent codon positions in the A-rich HIV RNA genome that do not easily become A: Restrictions imposed by the RNA sequence and structure
50. A combinatorial CRISPR-Cas12a attack on HIV DNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.